中國海油上市第二日繼續上漲逼近15元 較IPO價格漲38%
格隆匯4月22日丨中國海油(600938.SH)上市第二日繼續上漲,盤中一度漲超8%至14.97元;該股此次A股發行價格為10.8元/股,現價較IPO價格上漲38.6%。中國海油是國內最大的海上油氣生產運營商及天然氣生產商,也是全球最大的獨立油氣勘探及生產商之一。截至目前已累計獲得超過300個商業發現,現有油氣田超240個,年淨產量從2000年的88百萬桶油當量增至2021年的573百萬桶油當量;淨證實油氣儲量從2000年的17.6億桶油當量增至2021年的57.3億桶油當量。業內人士認為,中國海油的勘探空間與新能源業務的發展值得期待,有望打開更大的盈利空間,這也是諸多戰略投資者積極參與的原因之一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.